A prospective study to evaluate the effectiveness of positron emission mammography (PEM) in predicting the treatment outcome of chemotherapy in patients with breast cancer.

A prospective study to evaluate the effectiveness of positron emission mammography (PEM) in predicting the treatment outcome of chemotherapy in patients with breast cancer. - The evaluation of the effectiveness of PEM in breast cancer patients to predict the treatment outcome.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009314

Enrollment

Registered

2012-11-11

Start date

2012-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brast cancer

Interventions

Perform PEM scan for the breast cancer patients to evaluate the FDG uptake of the tumor, and to analyse the correlation with treatment outcome and survival date.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with breast cancer

Exclusion criteria

Exclusion criteria: 1.Pregnant and possibly pregnant women 2.Other patients determined to be inappropriate by physician

Design outcomes

Primary

Measure	Time frame
The evaluation of FDG uptake.	—

Secondary

Measure	Time frame
The correlation of FDG uptake with treatment outcome and prognosis.	—

Countries

Japan

Contacts

Public ContactAyako Shishikura

Graduate School of Medicine, Yokohama City University Department of Radiology

045-787-2696

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026